Equine Artificial Insemination Market Size, Share, Report 2023-2032
The global equine artificial insemination market was estimated at USD 0.67 billion in 2022 and it is expected to surpass around USD 1.18 billion by 2032, poised to grow at a CAGR of 5.83% from 2023 to 2032. The equine artificial insemination market in the United States was accounted for USD 168.2 million in 2022.
Key Pointers
Report Scope of the Equine Artificial Insemination Market
| Report Coverage | Details |
| Revenue Share of North America in 2022 | 32.57% |
| CAGR of Asia Pacific from 2023 to 2032 | 7.07% |
| Revenue Forecast by 2032 | USD 1.18 billion |
| Growth Rate from 2023 to 2032 | CAGR of 5.83% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Companies Covered | IMV Technologie; Stallion AI Services; Zoetis; Neogen Corporation; Zerlotti Genetics Ltd; ERC s.r.o., CVS (UK) Limited.; HOFFMAN A.I. BREEDERS INC.; Nasco; Continental Genetics, LLC; MINITÜB GMBH; Sussex Equine Hospital |
The adoption of normal semen in developing economies, the rise in demand for horse artificial insemination techniques, and the incessant demand to increase animal productivity and efficiency are among the primary factors propelling the growth of the market. Additionally, favorable campaigns, an increase in the number of veterinarians, and an increase in the number of hospitals performing artificial insemination procedures in both developed and developing countries are propelling market growth.
Horse breeding in Europe focuses primarily on horse selection for sport and reproduction. Breeding horses for leisure forms a relatively small portion of the overall market. In Europe, profitability which comes from the sale or leasing of horses is the fundamental promise of horse reproduction. In Europe, horse breeds are chosen based on the animal's ancestry, athletic accomplishments, and temperament. The cost of a stallion's sperm is the deciding factor when selecting a sire. Moreover, the sexing of sperm, low-dose deep intrauterine insemination, and intracytoplasmic sperm injection are recent developments in horse insemination.
The equine artificial insemination (AI) market growth is further driven due to the presence of institutions with advanced levels of training, research into new technologies and procedures, and progress in the field of horse reproduction. For instance, EquiBreed UK Ltd focuses on equine reproduction. The company is organized to deliver the best reproductive outcomes for a breeding program for mares, stallions, or horses. Among other things, the organization provides stallion services, stud facilities, artificial insemination, and embryo transfer.
As per the American Horse Council, the horse business in the United States is a sizable, economically diverse sector that makes a considerable contribution to the national economy. The horse industry had a direct employment impact of 988,394 jobs and a direct economic impact on the U.S. economy of over $50 billion in 2017. In addition, $38 billion in direct wages, salaries, and advantages are provided by the industry itself. The impact of the horse business extends beyond these immediate implications to other economic areas. Rising industry collaborations, partnerships with NGOs, and funding activities are further anticipated to provide this market with growth opportunities.
The COVID-19 epidemic triggered multiple obstacles for the equine artificial insemination market. This consisted of threats and uncertainty brought on by shifting consumer trends in several significant marketplaces, risks associated with implementing AI procedures locally, and low demand for AI products and services. The owners additionally demanded artificial insemination services delivered to their houses during the period of downtime. These operations subsequently contributed to the growth of the equine artificial insemination industry.
Solution Insights
In 2022, the services segment held the largest market share of over 41.03%. Training, synchronization, and artificial insemination are among the services provided. The growing number of universities that provide horse reproduction courses and studies contributes to the segment’s growth. For instance, Texas A&M University's Agriculture & Life Science department offers a short course on equine reproductive management. The training is intended for owners and breeding managers who wish to understand the most effective strategies for guaranteeing the success of their breeding programs. The course covers the anatomy and physiology of mares and stallions as well as gestation and foaling, feeding broodmares and young horses, controlling the estrous cycle, and manipulating mares' estrous cycles.
The semen segment is expected to witness the fastest growth at a CAGR of 6.36% over the forecast period. This is attributed to the high fertility rates in horses. According to the My Horse University, A conception rate of 65% is considered to be average for a farm that breeds horses. This means that during the upcoming mating season, 35% of all mares that have given foal will be inactive. Age is the main factor affecting mare fertility, with fertility frequently start decreasing at the age of 12. Fertility also has an impact on a stud farm's output and financial performance. It must be carefully evaluated at the level of the stallion and the mare as well as at the scale of the broodmare band and the farm to help the breeder make the best choices. From the time a stallion is bought until it is retired, semen analysis is utilized to track changes in semen quality.
Equine Type Insights
The Sports/racing equines segment accounted for the largest revenue share in 2022 and is expected to witness the fastest growth at a CAGR of 6.11% over the forecast period. Compared to recreational activities, horses are typically used for tourism, horse racing, and betting. Worldwide, warmblood horses are used for the Olympic sports of eventing, show jumping, and dressage. Numerous breeding organizations run selection programs for these sports horses, especially in Europe.
Breeding organizations have been exchanging large amounts of breeding stock internationally for many years. Significant advancements in reproduction methods, including the use of refrigerated and frozen semen, have made it possible for breeding stallions to be used concurrently in several nations. While countries with small populations frequently import breeding stock, those with large sport horse populations, like Germany and France, frequently export sport horses.
Distribution Channel Insights
The private segment accounted for a major market share in 2022 and is expected to witness the fastest growth at a CAGR of 6.06% over the forecast period. The private segment includes all private service providers for racehorses or others. For instance, Cryoport, Inc., a leading supplier of advanced cryogenic logistics solutions for the life sciences industry, established its cryogenic logistics solutions within the animal husbandry market by signing a new customer agreement with Yancey Farms to support the shipment of equine semen for artificial insemination of top German Sport horse Stallions.
A multi-billion dollar enterprise, animal husbandry encompasses the breeding of animals by humans to further develop desired genetic traits and behavior. The term "selection" can be used to describe the process of selectively breeding and nurturing animals to encourage desirable features in animals for use, sport, or research.
Additionally, Stallion AI Services, Hoffman AI Breeders, and numerous other independently owned companies all provide equine AI services. For example, Hoffman AI Breeders offers stallion semen collection and freezing services. Furthermore, Stallion AI Services, the most recognized supplier of equine reproduction services worldwide, is a world expert in the collection, processing, storage, and distribution of equine semen. The company's professional and specialized team has done over 20,000 collections from more than 1,200 stallions over the past 22 years.
Regional Insights
North America dominated the market in 2022, accounting for the largest market share of 32.57%. It is anticipated to maintain this position over the forecast period. According to the Food and Agriculture Organization of the United States, there were around 10.56 million horses in 2021, including 10.96 million horses in the North America region. In addition, the number of horse farms and the frequency of horse races both contributed to the growth of the market. In the United States, there are over 300 racetracks, and every year, about 33,567 horses take part in these races. Additionally, the import of 18,865 horses into the United States in 2021 has increased the need for equine AI in North America.
The Asia Pacific region is expected to witness the fastest growth at a CAGR of 7.07% over the forecast period. Asia Pacific is primarily driven by China and Japan. Japan has one of the largest racing horses & events. Horse racing in Japan is a popular equestrian sport, with more than 21,000 horse races held each year. Horse racing continues to be a Japanese tradition, though it has since become Westernized. Nowadays, all the top racing events in Japan are run by the National Association of Racing (NAR) and the Japan Racing Association (JRA).
Equine Artificial Insemination Market Segmentations:
By Solution
By Equine Type
By Distribution
By Regional
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Solution Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Equine Artificial Insemination Market
5.1. COVID-19 Landscape: Equine Artificial Insemination Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Equine Artificial Insemination Market, By Solution
8.1. Equine Artificial Insemination Market, by Solution, 2023-2032
8.1.1 Equipment & Consumables
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Semen
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Services
8.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Equine Artificial Insemination Market, By Equine Type
9.1. Equine Artificial Insemination Market, by Equine Type, 2023-2032
9.1.1. Sports/Racing
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Recreation
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Others
9.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Equine Artificial Insemination Market, By Distribution Channel
10.1. Equine Artificial Insemination Market, by Distribution Channel, 2023-2032
10.1.1. Private
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Public
10.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Equine Artificial Insemination Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Solution (2020-2032)
11.1.2. Market Revenue and Forecast, by Equine Type (2020-2032)
11.1.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Solution (2020-2032)
11.1.4.2. Market Revenue and Forecast, by Equine Type (2020-2032)
11.1.4.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Solution (2020-2032)
11.1.5.2. Market Revenue and Forecast, by Equine Type (2020-2032)
11.1.5.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Solution (2020-2032)
11.2.2. Market Revenue and Forecast, by Equine Type (2020-2032)
11.2.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Solution (2020-2032)
11.2.4.2. Market Revenue and Forecast, by Equine Type (2020-2032)
11.2.4.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Solution (2020-2032)
11.2.5.2. Market Revenue and Forecast, by Equine Type (2020-2032)
11.2.5.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Solution (2020-2032)
11.2.6.2. Market Revenue and Forecast, by Equine Type (2020-2032)
11.2.6.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Solution (2020-2032)
11.2.7.2. Market Revenue and Forecast, by Equine Type (2020-2032)
11.2.7.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Solution (2020-2032)
11.3.2. Market Revenue and Forecast, by Equine Type (2020-2032)
11.3.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Solution (2020-2032)
11.3.4.2. Market Revenue and Forecast, by Equine Type (2020-2032)
11.3.4.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Solution (2020-2032)
11.3.5.2. Market Revenue and Forecast, by Equine Type (2020-2032)
11.3.5.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Solution (2020-2032)
11.3.6.2. Market Revenue and Forecast, by Equine Type (2020-2032)
11.3.6.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Solution (2020-2032)
11.3.7.2. Market Revenue and Forecast, by Equine Type (2020-2032)
11.3.7.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Solution (2020-2032)
11.4.2. Market Revenue and Forecast, by Equine Type (2020-2032)
11.4.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Solution (2020-2032)
11.4.4.2. Market Revenue and Forecast, by Equine Type (2020-2032)
11.4.4.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Solution (2020-2032)
11.4.5.2. Market Revenue and Forecast, by Equine Type (2020-2032)
11.4.5.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Solution (2020-2032)
11.4.6.2. Market Revenue and Forecast, by Equine Type (2020-2032)
11.4.6.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Solution (2020-2032)
11.4.7.2. Market Revenue and Forecast, by Equine Type (2020-2032)
11.4.7.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Solution (2020-2032)
11.5.2. Market Revenue and Forecast, by Equine Type (2020-2032)
11.5.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Solution (2020-2032)
11.5.4.2. Market Revenue and Forecast, by Equine Type (2020-2032)
11.5.4.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Solution (2020-2032)
11.5.5.2. Market Revenue and Forecast, by Equine Type (2020-2032)
11.5.5.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
Chapter 12. Company Profiles
12.1. IMV Technologie
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Stallion AI Services
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Zoetis
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Neogen Corporation
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Zerlotti Genetics Ltd
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. ERC s.r.o., CVS (UK) Limited.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. HOFFMAN A.I. BREEDERS INC.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Nasco
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Continental Genetics, LLC
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. MINITÜB GMBH
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers